367 related articles for article (PubMed ID: 23216534)
1. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study.
Yeh YC; Liu CL; Peng LN; Lin MH; Chen LK
Geriatr Gerontol Int; 2013 Jul; 13(3):694-700. PubMed ID: 23216534
[TBL] [Abstract][Full Text] [Related]
2. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
3. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
4. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
[TBL] [Abstract][Full Text] [Related]
6. Delaying cognitive and physical decline through multidomain interventions for residents with mild-to-moderate dementia in dementia care units in Taiwan: A prospective cohort study.
Liang CK; Chou MY; Chen LY; Wang KY; Lin SY; Chen LK; Lin YT; Liu TY; Loh CH
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():36-43. PubMed ID: 28436184
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.
Koshoedo S; Soiza RL; Purkayastha R; Mangoni AA
Am J Geriatr Pharmacother; 2012 Aug; 10(4):251-7. PubMed ID: 22795433
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of anticholinergic burden of medications in older adults.
West T; Pruchnicki MC; Porter K; Emptage R
J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic Exposure During Rehabilitation: Cognitive and Physical Function Outcomes in Patients with Delirium Superimposed on Dementia.
Kolanowski A; Mogle J; Fick DM; Campbell N; Hill N; Mulhall P; Behrens L; Colancecco E; Boustani M; Clare L
Am J Geriatr Psychiatry; 2015 Dec; 23(12):1250-1258. PubMed ID: 26419732
[TBL] [Abstract][Full Text] [Related]
10. Use of medications with anticholinergic properties and cognitive function in a young-old community sample.
Low LF; Anstey KJ; Sachdev P
Int J Geriatr Psychiatry; 2009 Jun; 24(6):578-84. PubMed ID: 19021151
[TBL] [Abstract][Full Text] [Related]
11. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
12. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.
Sittironnarit G; Ames D; Bush AI; Faux N; Flicker L; Foster J; Hilmer S; Lautenschlager NT; Maruff P; Masters CL; Martins RN; Rowe C; Szoeke C; Ellis KA;
Dement Geriatr Cogn Disord; 2011; 31(3):173-8. PubMed ID: 21389718
[TBL] [Abstract][Full Text] [Related]
13. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial.
Kersten H; Molden E; Tolo IK; Skovlund E; Engedal K; Wyller TB
J Gerontol A Biol Sci Med Sci; 2013 Mar; 68(3):271-8. PubMed ID: 22982689
[TBL] [Abstract][Full Text] [Related]
14. Role of anticholinergic burden in primary care patients with first cognitive complaints.
Grande G; Tramacere I; Vetrano DL; Clerici F; Pomati S; Mariani C; Filippini G;
Eur J Neurol; 2017 Jul; 24(7):950-955. PubMed ID: 28503836
[TBL] [Abstract][Full Text] [Related]
15. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures.
Mangoni AA; van Munster BC; Woodman RJ; de Rooij SE
Am J Geriatr Psychiatry; 2013 Aug; 21(8):785-93. PubMed ID: 23567395
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Anticholinergic Medication Use in the Program of All-Inclusive Care for the Elderly.
Covington LP; McCarrell J; Hoerster NS
Consult Pharm; 2016 Mar; 31(3):168-74. PubMed ID: 26975596
[TBL] [Abstract][Full Text] [Related]
17. Impact of multiple low-level anticholinergic medications on anticholinergic load of community-dwelling elderly with and without dementia.
Mate KE; Kerr KP; Pond D; Williams EJ; Marley J; Disler P; Brodaty H; Magin PJ
Drugs Aging; 2015 Feb; 32(2):159-67. PubMed ID: 25566958
[TBL] [Abstract][Full Text] [Related]
18. Risk of hospitalization associated with anticholinergic medication for patients with dementia.
Watanabe S; Fukatsu T; Kanemoto K
Psychogeriatrics; 2018 Jan; 18(1):57-63. PubMed ID: 29372598
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
20. Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia.
Hsu TJ; Tsai HT; Hwang AC; Chen LY; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():28-35. PubMed ID: 28436192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
